In California, Codexis, reported revenues for the third quarter of 2012 of $26.3 million, a 21% decrease from $33.3 million in the third quarter of 2011. Product revenue in the third quarter of 2012 was $7.1 million, a 41% decrease from $12.2 million in the prior year quarter and a 5% sequential increase from $6.8 […]
Biofuels Digest has released the next wave of its 5-Minute Guides – a “news you can use” digest on the leading companies in biofuels. Each 5-Minute Guide provides a company description, 3 top milestones for 2010-12 and projected for 2012-14, description of the business model; plus project info (location, feedstocks, product set, processing technology, capacity, […]
Address: 200 Penobscot Drive Redwood City, CA 94063 Year founded 2002 Annual Revenues: $107 million (2010) Company description: Codexis serves major worldwide markets where clean technology can make a positive economic and environmental impact. Codexis CodeEvolver ™ directed evolution technology accelerates development of high value sustainable products. Our focus is on the cost-effective conversion of […]
Codexis, Shell redefine relationship; Codexis gains global rights; will lay off 133 staff; adopts anti-takeover measures; what does it mean for Shell, Raizen, Iogen, Codexis and Dyadic? What does it say about strategic investors in advanced biofuels? In California, Codexis announced that Shell has granted Codexis a royalty-bearing, non-exclusive license to develop, manufacture, use and […]
In California, Codexis announced the appointment of David O’Toole as Senior Vice President and Chief Financial Officer, effective September 4, 2012. O’Toole served most recently as Vice President and Chief Financial Officer at Response Genetics, Inc. (NASDAQ: RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer and analytical testing services of […]
In California, Codexis announced that the company has signed an agreement with Shell to expand Codexis’ ability to commercialize its CodeXymeTM cellulase enzymes under a royalty-bearing, non-exclusive license to develop, manufacture, use and sell cellulase enzymes developed according to the companies’ Amended and Restated Collaborative Research Agreement. It also announced a workforce reduction as part of […]
Codexis expects to lose all of Shell funding, win freedom to operate globally (excepting Brazil). Pyrrhic victory or the necessary price of freedom? In California, Codexis (CDXS) announced that it expects to obtain rights from Shell to market its CodeXyme cellulase enzymes to other cellulosic biofuels developers, (excluding Brazil) and that Shell will discontinue its […]
In California, Codexis announced that the company has signed an Exclusive Negotiation Agreement with Shell. Under this agreement, Shell has agreed to negotiate exclusively with Codexis through September 1, 2012 the terms of a new agreement under which Shell would grant to the company certain rights and licenses in the biofuels field to develop and […]
In California, Codexis announced that a pilot-scale demonstration of the company’s carbon capture technology conducted at the National Carbon Capture Center (NCCC) in Wilsonville, Alabama, on flue gas emitted from a Southern Company power plant, shows that enzymes have promise to facilitate CO2 capture at coal-fired power plants. This is the largest scale that enzyme-based […]
In California, Codexis announced that Joe Sarret has resigned as Senior Vice President and Chief Business Officer, effective August 3, 2012.
